pharmaceuticals-and-healthcare

2012-2022 Report on Global Cancer Treatment Drugs Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application


Published On : Mar 2017

Category : Cancer

No. of Pages : 116 pages

  • $2958
  • $5916

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Summary

In the last several years, Global market of Cancer Treatment Drugs developed rapidly, with an average growth rate of 8.56%. In 2015, Global revenue of Cancer Treatment Drugs is nearly 107 billion USD.

This report studies Cancer Treatment Drugs in Global market, especially in North America, Europe, Japan, Asia (ex. Japan), focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
Bristol-Myers Squibb
Takeda
Eli Lilly
Pfizer
AstraZeneca
Astellas
Sanofi
Bayer
Merck & Co.
Biogen Idec
Kyowa Hakko Kirin
Otsuka
Teva
Eisai
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

Market Segment by Regions, this report splits Global into several key Regions, with revenue, consumption, market share and growth rate of Cancer Treatment Drugs in these regions, from 2011 to 2021 (forecast), like
North America
Europe
Japan
China
India
Southeast Asia
RoW

Split by Product Types, with revenue, market share and growth rate of each type, can be divided into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others

Split by applications, this report focuses on consumption, market share and growth rate of Cancer Treatment Drugs in each application, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

Cancer is a group of ailments that involves abnormal growth of the cells with the prospective of invading or spreading in other parts of the body, thus affecting it. However, not all tumors are likely to turn cancerous such as benign tumors do not multiply into other parts of the body. The probable symptoms and signs comprise alteration in bowel movements, unnatural weight loss, prolonged cough, abnormal bleeding, and lump.

This research study contained by the global industry of cancer can be termed as an all-inclusive databank on the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market. The purpose of this report’s compilation is to throw light on all the major aspects of the market and the various facets that are responsible for molding its functionalities. The 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market is described on the basis of the factors surrounding its economic and legal governing aspects, key segmentations through products and geography, and a descriptive analysis of its value chain in entirety. This is attained through the gathering of data gained from primary and secondary sources pertaining precisely to the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market. The data given in the report has been skilfully assembled by experienced analysts and complemented by the appropriate visual illustrations. Due to the precision-driven data provided in the report and the reliable models of analysis that are used, this report drives home as a necessary tool for players of all sizes in the cancer and cancer cure products industries around the world.

Current, contemporary, and projected data have been cooperatively provided within a single report on the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market. A lot of these characteristics are about the macro and microeconomic factors that have, are, and are will likely continue to impact the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market. These factors have been surveyed at extent within the report, and the effect of the factors on the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market at present is also examined and forecasts for the market’s progress in the forecast period are presented in the report. The development of the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market is additionally extrapolated within the given forecast period.

The segmentation of the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market is dealt with great care and in high quality detail, as each segment is analyzed at a microscopic level to present a top to bottom view of the market for the reader. The analysis of the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market is accomplished in a highly systematic manner and will help everyone from the leading players to the new entrants to figure out what strategies are valuable to them in order to adopt. They can move on to instrument the right ones to achieve the most maintainable development plan within the given forecast period. Tools of analysis such as the SWOT analysis and Porter’s five forces analysis additionally provide a descriptive study of the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market for a specifically competitive viewpoint. The relative share of each segment in the 2012 2022 report on global cancer treatment drugs market competition status and forecast market size by players regions type application market is presented in this report, aiding users to build a detailed and complete snapshot of the market and its position in the cancer industry.

List of Tables and Figures

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure Global Revenue Market Share of Cancer Treatment Drugs by Types in 2015
Figure Product Picture of Chemotherapy
Figure Product Picture of Targeted Therapy
Figure Product Picture of Immunotherapy (Biologic Therapy)
Figure Product Picture of Hormonal Therapy
Table Applications of Cancer Treatment Drugs
Table Cancer Treatment Drugs Consumption Value Market Share by Applications in 2015
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure Gastrointestinal Cancer Examples
Figure Prostate Cancer Examples
Figure Respiratory/Lung Cancer Examples
Figure North America Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Japan Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Global Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Cancer Incidence by Country in 2015
Figure Cancer Mortality by Country in 2015
Figure USA numbers of new cancer cases for 2015
Figure Canada numbers of new cancer cases for 2015
Figure EU numbers of new cancer cases for 2015
Figure Med- East numbers of new cancer cases for 2015
Figure Africa numbers of new cancer cases for 2015
Figure China numbers of new cancer cases for 2015
Figure Japan numbers of new cancer cases for 2015
Figure South East Asia numbers of new cancer cases for 2015
Table Global Cancer Treatment Drugs Revenue (M USD) of Key Manufacturers (2015 and 2016)
Table Global Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Treatment Drugs Revenue Market Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Revenue Market Share by Manufacturers
Table Global Cancer Treatment Drugs Gross Margin by Manufacturers (2015 and 2016)
Figure 2015 Global Cancer Treatment Drugs Gross Margin by Manufacturers
Figure 2016 Global Cancer Treatment Drugs Gross Margin by Manufacturers
Table 2016 Global Cancer Treatment Drugs Gross (M USD) by Manufacturers
Figure 2015 Global Cancer Treatment Drugs Gross by Manufacturers
Figure 2016 Global Cancer Treatment Drugs Gross by Manufacturers
Table Manufacturers Cancer Treatment Drugs Headquarters and Founded Date
Table Manufacturers Cancer Treatment Drugs Main Brands
Table Cancer Treatment Drugs Top 10 brand, Manufacturers and Revenue in 2016
Table Global Cancer Treatment Drugs Revenue (M USD) by Regions (2012-2017)
Table Global Cancer Treatment Drugs Revenue Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Treatment Drugs Revenue Market Share by Regions
Figure 2016 Global Cancer Treatment Drugs Revenue Market Share by Regions
Table Global Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table North America Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Europe Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Japan Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value (M USD) Market by Regions (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value Market Share by Regions (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Treatment Drugs Consumption Value Market Share by Regions
Figure 2016 Global Cancer Treatment Drugs Consumption Value Market Share by Regions
Figure North America Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Japan Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure China Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure India Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Southeast Asia Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Table North America Cancer Treatment Drugs Import & Export (2012-2017)
Table Europe Cancer Treatment Drugs Import & Export (2012-2017)
Table Japan Cancer Treatment Drugs Import & Export (2012-2017)
Table Asia (ex. Japan) Cancer Treatment Drugs Import & Export (2012-2017)
Table Global Cancer Treatment Drugs Revenue (M USD) by Types (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Types (2012-2017)
Figure Revenue Market Share of Cancer Treatment Drugs by Types (2012-2017)
Figure 2015 Revenue Market Share of Cancer Treatment Drugs by Types
Figure 2016 Revenue Market Share of Cancer Treatment Drugs by Types
Figure Global Cancer Treatment Drugs Revenue Growth by Type (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value (M USD) by Application (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value Market Share by Application (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Market Share by Application in 2015
Figure 2015 Consumption Value Market Share by Application (2012-2017)
Figure 2016 Consumption Value Market Share by Application (2012-2017)
Table Global Cancer Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Growth Rate by Application (2012-2017)
Table Roche Company Profile
Figure Cancer Treatment Drugs Product Picture of Roche
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2015-2016
Table Novartis Company Profile
Figure Cancer Treatment Drugs Product Picture of Novartis
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Novartis 2015-2016
Table Celgene Company Profile
Figure Cancer Treatment Drugs Product Picture of Celgene
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Celgene 2015-2016
Table Amgen Company Profile
Figure Cancer Treatment Drugs Product Picture of Amgen
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Amgen 2015-2016
Table Johnson & Johnson Company Profile
Figure Cancer Treatment Drugs Product Picture of Johnson & Johnson
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Johnson & Johnson 2015-2016
Table Bristol-Myers Squibb Company Profile
Figure Cancer Treatment Drugs Product Picture of Bristol-Myers Squibb
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bristol-Myers Squibb 2015-2016
Table Takeda Company Profile
Figure Cancer Treatment Drugs Product Picture of Takeda
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2015-2016
Table Eli Lilly Company Profile
Figure Cancer Treatment Drugs Product Picture of Eli Lilly
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2015-2016
Table Pfizer Company Profile
Figure Cancer Treatment Drugs Product Picture of Pfizer
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Pfizer 2015-2016
Table AstraZeneca Company Profile
Figure Cancer Treatment Drugs Product Picture of AstraZeneca
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of AstraZeneca 2015-2016
Table Astellas Company Profile
Figure Cancer Treatment Drugs Product Picture of Astellas
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Astellas 2015-2016
Table Sanofi Company Profile
Figure Cancer Treatment Drugs Product Picture of Sanofi
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Sanofi 2015-2016
Table Bayer Company Profile
Figure Cancer Treatment Drugs Product Picture of Bayer
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bayer 2015-2016
Table Merck & Co. Company Profile
Figure Cancer Treatment Drugs Product Picture of Merck & Co.
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck & Co. 2015-2016
Table Biogen Idec Company Profile
Figure Cancer Treatment Drugs Product Picture of Biogen Idec
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Biogen Idec 2015-2016
Table Kyowa Hakko Kirin Company Profile
Figure Cancer Treatment Drugs Product Picture of Kyowa Hakko Kirin
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kyowa Hakko Kirin 2015-2016
Table Otsuka Company Profile
Figure Cancer Treatment Drugs Product Picture of Otsuka
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Otsuka 2015-2016
Table Teva Company Profile
Figure Cancer Treatment Drugs Product Picture of Teva
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Teva 2015-2016
Table Eisai Company Profile
Figure Cancer Treatment Drugs Product Picture of Eisai
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eisai 2015-2016
Table Merck KGaA Company Profile
Figure Cancer Treatment Drugs Product Picture of Merck KGaA
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck KGaA 2015-2016
Table Ipsen Company Profile
Figure Cancer Treatment Drugs Product Picture of Ipsen
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Ipsen 2015-2016
Table AbbVie Company Profile
Figure Cancer Treatment Drugs Product Picture of AbbVie
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of AbbVie 2015-2016
Table Gilead Sciences Company Profile
Figure Cancer Treatment Drugs Product Picture of Gilead Sciences
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Gilead Sciences 2015-2016
Figure New Active Substance Launches 2011-2015 by Indication
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015
Figure Key In-Market and Investigational Agents for NSCLC
Figure Key In-Market and Investigational Agents for Melanoma
Figure the Global Late Phase Oncology Pipeline in 2015
Figure Companies with Active Late Phase Oncology Pipelines
Figure Global GDP Map 2016
Figure EU GDP Change 2005-2016
Figure German CPI Change 2011-2015
Figure UK CPI Change 2011-2015
Figure Japan GDP Change 2005-2016
Figure Japan CPI Change 2011-2015
Figure China GDP Change 2005-2016
Figure China CPI Change 20011-2015
Figure China PPI Growth Rate 2011-2015
Figure US GDP Change 2005-2016
Figure US CPI Change 2011-2015
Figure Out-of-pocket Expenditure on Health as a Percentage of Total Expenditure on Health (%) in 2014
Figure Total Expenditure on Health as a Percentage of GDP (%) in 2014
Figure Global Average Health Expenditure, Total (% of GDP)
Table USA Health Expenditure Ratios from 1995-2016
Table China Health Expenditure Ratios from 1995-2016
Table Japan Health Expenditure Ratios from 1995-2016
Table Germany Health Expenditure Ratios from 1995-2016
Table UK Health Expenditure Ratios from 1995-2016
Table India Health Expenditure Ratios from 1995-2016
Table Canada Health Expenditure Ratios from 1995-2016
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Upstream Raw Materials Sourcing
Table Major Buyers of Cancer Treatment Drugs
Figure Marketing Channel for Biopharmaceuticals
Table Some of Famous Hospital
Table Distributors/Traders List
Figure Global Cancer Treatment Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022)
Table Global Cancer Treatment Drugs Revenue (M USD) Forecast by Regions (2017-2022)
Figure North America Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Europe Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Japan Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Table Global Cancer Treatment Drugs Consumption Value (M USD) Forecast by Regions (2017-2022)
Figure North America Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Europe Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Japan Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure China Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure India Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Southeast Asia Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Table Global Cancer Treatment Drugs Revenue (M USD) Forecast by Type (2017-2022)
Table Global Cancer Treatment Drugs Consumption (Value) Forecast by Application (2017-2022)




Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top